Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


In this issue


Illustration of gastro-oesophageal reflux

Time to halt the overprescribing of proton pump inhibitorsSubscription


Inappropriate use of proton pump inhibitors can cause a range of side effects and even harm to patients.

CPD article

Illustration antibiotic destroying bacteria

Principles of initiating antimicrobial therapy and empiric prescribingSubscription


Healthcare professionals should be aware of the principles of antimicrobial treatment and the need to reduce inappropriate prescribing to retain the effectiveness of drugs currently available.


Scanning electron micrograph of nasal mucosa in allergic rhinitis

Allergic rhinitis: impact, diagnosis, treatment and managementSubscription

By , ,

Allergic rhinitis results from an immunological abnormality in which atopic individuals produce immunoglobulin E (IgE) to allergens (e.g. pollen, house dust mites, animal dander and moulds). IgE activates mast cells, which respond by releasing inflammatory mediators. Histamine stimulates the early symptoms, predominately mucus production, nasal itching and sneezing. Leukotrienes and cytokines attract and activate eosinophils to cause allergic inflammation, which is primarily responsible ...

Research Article

Close-up of a person taking a dry-blood spot test

Integrating community pharmacy testing for hepatitis C with specialist careSubscription

By , Pembe Hassan-Hicks, Kevin Noble, Leonie Grellier, Julie Parkes, Salim I Khakoo

Many patients with hepatitis C virus (HCV) infection lie undiagnosed and a significant proportion of patients that have been identified are disengaged from specialist services. The Isle of Wight (IOW) typifies this issue, with an estimated 200 undiagnosed patients with HCV infection and a small number of known cases engaged with specialist services. Aim: To reduce the burden of undiagnosed HCV on the IOW and link new diagnoses directly ...

Short Communications

Why are hepatitis C patients treated differently by NHS England?Subscription


NHS England’s decision to cap access to National Institute for Health and Care Excellence (NICE) approved hepatitis C treatments has been attributed to their cost. These antiviral medicines have led to vast costs for national healthcare systems and huge profits for the pharmaceutical industry. So it is understandable that the mainstream media and general public assume that the cost to the NHS (either per patient or in absolute terms) is prohibitive.

Referral delays for arthritis patients could have devastating consequencesSubscription


I would like to highlight the devastating consequences that delayed referrals are having on people with inflammatory arthritis.

'Don’t wait to anticoagulate' projectSubscription


I was interested to read the news story ‘Many atrial fibrillation patients at risk of stroke treated with aspirin over anticoagulants’ (The Pharmaceutical Journal online, 24 June 2016), which outlines the finding that significant numbers of patients with atrial fibrillation (AF) are not being prescribed the most effective form of ...

Clinical Pharmacist

CP August 2016, Vol 8, No 8

Cover Story:

Pharmacy-based hepatitis C testing and referral service

Read more…

Clinical Pharmacist

View previous issue

Clinical Pharmacist is a monthly, peer-reviewed journal that provides authoritative resources on the clinical management of disease in relation to medicines and up-to-date information about advances in pharmacy and drug development. Clinical Pharmacist publishes Review articles, Perspectives, evidence-based CPD articles and Research articles on topics from drug discovery to clinical pharmacology and pharmacy.

The international audience of Pharmaceutical Journal Publications consists of pharmacists, pharmaceutical scientists and healthcare professionals. The journal is available to 44,000 members of the Royal Pharmaceutical Society, as well as non-member individual subscribers and subscribing institutions.